Nektar Restructures A Second Time, Focusing Squarely On Immunology

 
• By Joseph Haas
  
severing ties and boycott concept
Nektar slashed headcount to push its cash runway to 2026
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business